Moreover, patients whose GC simultaneously expressed RET and GFRAL at a high level had significantly shorter survival time compared to those patients whose tumor tissue expressed both these markers at a low level (474 days vs. 2197 days, P = 0.0002; Figure 3G). The gene discussed is GFRAL; the disease is neoplasm.